Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Injection that cuts LDL cholesterol by about 60%. | Cholesterol injection given twice a year. |
| Body system | Heart & Cholesterol | Heart & Cholesterol |
| Drug class | PCSK9 inhibitors | PCSK9 inhibitors |
| Supply | Prescription only | Prescription only |
| Main uses | High LDL cholesterol despite statins, Familial hypercholesterolaemia, Established cardiovascular disease | High LDL cholesterol despite statins, Familial hypercholesterolaemia |
| How it works | Stops a protein from destroying the liver's cholesterol 'catchers'. | Switches off the liver's instructions to make PCSK9. |
| Starts working | — | — |
| Half-life | 11–17 days | — |
| Typical adult dose | 140 mg every 2 weeks or 420 mg once a month under the skin. | 284 mg under the skin at day 0, at 3 months, then every 6 months. |
| Forms | Pre-filled pen injection | Pre-filled syringe |
| Common side effects | Injection-site reactions, Cold-like symptoms, Back pain | Injection-site reactions, Joint pain |
| Serious side effects | Allergic reactions (rare) | None common in trials |
| Don't take if | — | — |
| Alcohol | — | — |
| Pregnancy | Use with cautionAntibodies cross the placenta later in pregnancy; limited data. | Use with cautionNot recommended; no data. |
| Breastfeeding | — | — |
| In use since | 2015 | 2020 |
| Brand names | United States: RepathaUnited Kingdom: RepathaIndia: Repatha | United States: LeqvioUnited Kingdom: LeqvioIndia: Sybrava |
| Legal status | — | — |
| ATC code | C10AX13 | C10AX16 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker